Genesis Healthcare, Inc. (NYSE:GEN) is reporting second quarter earnings results on Monday 10th August 2020, after market close.
The consensus estimates from Thomson Reuters are loss of $ 0.03 per share.
For the full year, analysts predict revenues of $ 4346.90 million, while looking forward to loss of $ 0.12 per share.
Previous Quarter Performance
Genesis Healthcare, Inc. disclosed income for the first quarter of $ 0.28 per share, from the revenue of $ 1,092.00 million. The quarterly earnings shrunk 8.00 percent while revenues compared with the same quarter last year.
Street analysts expected Genesis Healthcare, Inc. to report loss of $ 0.02 per share on revenue of $ 1,090.00 million for the first quarter. The bottom line results beat street analysts by $ 0 or , at the same time, top line results outshined analysts by $ 2.00 million or 0.18 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of Genesis Healthcare, Inc.
Stock Performance
According to the previous trading day, closing price of GEN was $ 1.02, representing a 75.86 % increase from the 52 week low of $ 0.58 and a 45.16 % decrease over the 52 week high of $ 1.86.
The company has a market capital of $ 169.60 million and is part of the Healthcare sector and Long-Term Care Facilities industry.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”GEN” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.
